Literature DB >> 2783487

Transplantation tolerance correlates with high levels of T- and B-lymphocyte activity.

A Bandeira1, A Coutinho, C Carnaud, F Jacquemart, L Forni.   

Abstract

Mice tolerized (treated to make them tolerant) at birth to transplantation antigens by injection of semiallogeneic cells contain very high numbers of activated T and B lymphocytes in their spleen. Lymphoid hyperactivity correlates with the tolerant state: it is present only in animals accepting skin allografts. Tolerized mice that reject the allogeneic skin graft have approximately the same numbers of total and activated lymphocytes as normal mice. The high level of lymphocyte activation in tolerant mice persists for up to 1 year of age, although it declines with age, and is markedly increased by a secondary allograft. The magnitudes of both primary and secondary tolerant responses are significantly higher than the immunological response of a normal mouse rejecting the same type of allograft. These observations contradict concepts of clonal deletion or anergy as the basis of neonatally induced transplantation tolerance and may contribute additional approaches to experimentation and control of transplantation reactions.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2783487      PMCID: PMC286446          DOI: 10.1073/pnas.86.1.272

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  T cells mediate transplantation tolerance.

Authors:  S Dorsch; B Roser
Journal:  Nature       Date:  1975-11-20       Impact factor: 49.962

2.  Actively acquired tolerance of foreign cells.

Authors:  R E BILLINGHAM; L BRENT; P B MEDAWAR
Journal:  Nature       Date:  1953-10-03       Impact factor: 49.962

3.  Importance of chimerism in maintaining tolerance of skin allografts in mice.

Authors:  D M Lubaroff; W K Silvers
Journal:  J Immunol       Date:  1973-07       Impact factor: 5.422

4.  Use of fluorescent antibodies in the study of lymphoid cell membrane molecules.

Authors:  L Forni; S de Petris
Journal:  Methods Enzymol       Date:  1984       Impact factor: 1.600

5.  Internal complementarities in the immune system: regulation of the expression of helper T-cell idiotypes.

Authors:  C Martinez; P Pereira; R Bernabé; A Bandeira; E L Larsson; P A Cazenave; A Coutinho
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

6.  Suppressor cells in transplantation tolerance. I. Analysis of the suppressor status of neonatally and adoptively tolerized rats.

Authors:  S Dorsch; B Roser
Journal:  Transplantation       Date:  1982-05       Impact factor: 4.939

7.  Life-long tolerance and chimerism in parental mice induced with F 1 hybrid cells.

Authors:  V Silobrcić
Journal:  Eur J Immunol       Date:  1971-11       Impact factor: 5.532

8.  Monoclonal antibodies to mouse MHC antigens. III. Hybridoma antibodies reacting to antigens of the H-2b haplotype reveal genetic control of isotype expression.

Authors:  K Ozato; D H Sachs
Journal:  J Immunol       Date:  1981-01       Impact factor: 5.422

9.  A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.

Authors:  A Pierres; P Naquet; A Van Agthoven; F Bekkhoucha; F Denizot; Z Mishal; A M Schmitt-Verhulst; M Pierres
Journal:  J Immunol       Date:  1984-06       Impact factor: 5.422

10.  Immunocompetent autoreactive B lymphocytes are activated cycling cells in normal mice.

Authors:  D Portnoï; A Freitas; D Holmberg; A Bandeira; A Coutinho
Journal:  J Exp Med       Date:  1986-07-01       Impact factor: 14.307

View more
  9 in total

1.  Unresponsiveness to Mlsa induced in newborn Mlsb mice by maternal preimmunization.

Authors:  A Matossian-Rogers; L DeGiorgi; L DeGiori
Journal:  Immunology       Date:  1991-02       Impact factor: 7.397

Review 2.  Chronic rejection. A general overview of histopathology and pathophysiology with emphasis on liver, heart and intestinal allografts.

Authors:  A J Demetris; N Murase; R G Lee; P Randhawa; A Zeevi; S Pham; R Duquesnoy; J J Fung; T E Starzl
Journal:  Ann Transplant       Date:  1997       Impact factor: 1.530

Review 3.  Xenobiotics, chimerism and the induction of tolerance following organ transplantation.

Authors:  C P Delaney; A W Thomson; A J Demetris; T E Starzl
Journal:  Ther Immunol       Date:  1994-06

Review 4.  Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation.

Authors:  T E Starzl; A J Demetris; N Murase; A W Thomson; M Trucco; C Ricordi
Journal:  Immunol Today       Date:  1993-06

5.  Allogeneic hematolymphoid microchimerism and prevention of autoimmune disease in the rat. A relationship between allo- and autoimmunity.

Authors:  C P Delaney; N Murase; M Chen-Woan; J J Fung; T E Starzl; A J Demetris
Journal:  J Clin Invest       Date:  1996-01-01       Impact factor: 14.808

6.  Transplantation tolerance is unrelated to superantigen-dependent deletion and anergy.

Authors:  J Salaün; A Bandeira; I Khazaal; O Burlen-Defranoux; V Thomas-Vaslin; M Coltey; N M Le Douarin; A Coutinho
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

7.  Immunodeficiency in RFM/(T6xRFM)F1 mouse chimaeras with lethal host-versus-graft syndrome.

Authors:  R C Hard; J L Montour; B A Fuchs
Journal:  Clin Exp Immunol       Date:  1995-05       Impact factor: 4.330

8.  Tolerance in transgenic mice expressing class II major histocompatibility complex on pancreatic acinar cells.

Authors:  D Lo; L C Burkly; R A Flavell; R D Palmiter; R L Brinster
Journal:  J Exp Med       Date:  1989-07-01       Impact factor: 14.307

9.  Loss of epidermal integrity by T cell-mediated attack induces long-term local resistance to subsequent attack. I. Induction of resistance correlates with increases in Thy-1+ epidermal cell numbers.

Authors:  T Shiohara; N Moriya; C Gotoh; J Hayakawa; M Nagashima; K Saizawa; H Ishikawa
Journal:  J Exp Med       Date:  1990-04-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.